Acasti Pharma Announces Mailing of Management Information Circular and Amendment to Stock Option Plan Jul 31, 2018
Acasti Pharma Awarded Composition-of-Matter Patent by the U.S. Patent and Trademark Office Jul 24, 2018
Acasti Pharma Announces Annual Performance Grants of Stock Options, Amendment of Stock Option Plan and Issuance of Common Shares in Payment of Outstanding Interest under Debentures Jul 2, 2018
Acasti Pharma Reports on Positive Feedback Following Today’s Presentation at the XVIII International Symposium on Atherosclerosis Jun 11, 2018
Acasti Pharma Retains Crescendo Communications for Investor Relations Services in the United States May 18, 2018